Company Description

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.

The company offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.

It also researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.

Profusa, Inc. is based in Berkeley, California.

Profusa, Inc.

Country	United States
Founded	2009
Industry	Medical Devices
Sector	Healthcare
Employees	15
CEO	Ben Hwang

Contact Details

Address: 626 Bancroft Way, Suite A Berkeley, California 94710 United States
Phone	925 997 6925
Website	profusa.com

Stock Details

Ticker Symbol	PFSA
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001859807
Employer ID	86-3437271
SIC Code	3841

Key Executives

Name	Position
Dr. Ben Chung-Bin Hwang Ph.D.	Chief Executive Officer and Chairman
William McMillan	Co-founder, Chief Scientific Officer and Head of Research
Fred S. Knechtel	Chief Financial Officer and Director
David Icke	Head of Digital Health Business
Sean Givens	Head of Government Business
Phil Constantinou	Head of Software and Data Science

Latest SEC Filings

Date	Type	Title
Sep 26, 2025	424B3	Prospectus
Sep 23, 2025	DEF 14A	Other definitive proxy statements
Sep 17, 2025	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Sep 16, 2025	8-K	Current Report
Sep 10, 2025	PRE 14A	Other preliminary proxy statements
Sep 4, 2025	8-K	Current Report
Aug 29, 2025	S-1	General form for registration of securities under the Securities Act of 1933
Aug 26, 2025	8-K	Current Report
Aug 25, 2025	EFFECT	Notice of Effectiveness
Aug 25, 2025	424B3	Prospectus

View All SEC Filings